Looking at top Wall Street opinions, Tenaris S.A. (NYSE: TS) has recently made its way into the research list of Cowen – signaling that their analyst’s rating adjustment is noteworthy. This stock was Reiterated to a rating of Market Perform in the eyes of Cowen, as reported on Monday, August 5th, 2019. Another heavy-hitting research note was published by Goldman on Tuesday March 26th, 2019, with this firm downgrading TS to an updated rating of Sell from its previous rating of Neutral. In the past six months and three months of trading, shares of Tenaris S.A. (TS) have moved by -7.00% and -13.81%, respectively.
Brokerage Updates Related to Tenaris S.A. (TS) Stock
This publicly-traded organization generated losses of -4.79% over the last 5 sessions. Right now, this stock is the subject of 16 analysts’ evaluations, who – on average – have given this company’s shares a Buy rating. Of the latest market expert opinions, 1 have given an underperform rating, 0 has given a sell rating, and 5 have given a rating of Buy or better. Based on the 16 stock market experts following this company, the average 12-month price target is $33.83. Moreover, individual price targets range between $26.10-$37.88. With its recent move to $32.00, we can see that these firms project this stock will loss by -35.23% in one year.
Updates from Tenaris S.A. (TS) SEC Form 4
This particular company’s shares have garnered a lot of attention in recent days, as insiders are unloading their holdings while having generated a 60.60% rise since the beginning of the calendar year.
Tenaris S.A. (NYSE:TS) Results in the Pipeline
The next scheduled release of financial results for Tenaris S.A. will be for the Mar-19 quarter. As it stands right now, market analysts are anticipating the per-share earnings for the three-month period will be $0.38. In the same vein, they expect sales for the quarter to amount to $1,954.13 million.
Now let’s turn to earnings surprise history: in the most recent quarter, the company reported about $1,871.76 million in revenue alongside EPS at $0.41. On average, the analyst projection was calling for $2,104.98 million with $0.38 per share in earnings, respectively. In the preceding quarter, this company’s revenue reached $1,898.89 million, with earnings per share ending up at $0.42.
Plains GP Holdings, L.P. (NYSE:PAGP) experienced a drop of -3.37% from the closing price in the previous trading day. That drove the price to $22.07 per share, as observed on January 1st, 1970, at a time when the total trading volume reached 1,676,082 shares of stock – compared to the typical average of 1.61M shares per day (as recorded over the past three months). The consensus estimate for these shares has been shifted to $27.76.
Pricing Indications for Plains GP Holdings, L.P. (PAGP)
This organization has had a price-to-earnings ratio of 7.93 in the last year. Meanwhile, it gained 24.20 from its observable 50-day simple moving average. Right at this moment, the per-share value is -5.68% lower than the mean per-share price over the last 200 days in the market.
Plains GP Holdings, L.P. (NYSE:PAGP) In-Depth Brokerage Insights
We can see that a number of brokerage firms are putting their focus onto this stock. Out of this group, 0 have a sell rating, 8 have a Buy rating, 6 have an outperform rating, while 3 provided a Hold rating for these shares – thanks to data from Thomson Reuters I/B/E/S. Additionally, 0 have recommended that these shares are an Underperforming investment. The current consensus recommendation is at 1.80 , based on information from Thomson Reuters.
PAGP Stock Value Potential
In trading activity as of late, this stock’s value was 23.39 up from its 200 day moving average, while also -8.84% down when compared against its 50-day simple moving average. Over the course of the past year of trading, the share price stuck in the range of $25.00-$32.00. The market value for the entire organization reached 6.20B. In the last trading session, the price ended the day at $22.84. The institutional holdings related to this organization account for 0.20%, and the Beta factor is now 1.12. This company’s RSI (Relative Strength Index) managed to hit 26.38.
Plains GP Holdings, L.P. (NYSE:PAGP) Analyst Points of Focus
Plains GP Holdings, L.P. (PAGP) has found itself inside of Wolfe Research’s research list, so their analyst rating adjustment is worth taking note of. This stock was upgraded to Outperform, compared to its previous rating of Peer Perform by Wolfe Research, as garnered from a news report on Thursday June 13th, 2019. An additional helpful research note was sent out by Goldman’s on Thursday January 3rd, 2019. The brokerage decided to upgrade PAGP to Buy from its previous rating of Neutral.